Page last updated: 2024-08-23

pimonidazole and almokalant

pimonidazole has been researched along with almokalant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blomgren, B; Danielsson, BR; Dillner, B; Johansson, A; Sköld, AC1

Other Studies

1 other study(ies) available for pimonidazole and almokalant

ArticleYear
Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.
    Toxicology and applied pharmacology, 2003, Dec-01, Volume: 193, Issue:2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Arrhythmias, Cardiac; Cation Transport Proteins; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Female; Fetal Hypoxia; Image Processing, Computer-Assisted; Injections, Intravenous; Nitroimidazoles; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pregnancy; Propanolamines; Rats; Rats, Sprague-Dawley; Teratogens; Videotape Recording

2003